Evidence map›Paper›PMID 28757815›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2017

Insulin induces a shift in lipid and primary carbon metabolites in a model of fasting-induced insulin resistance.

Keedrian I Olmstead, Michael R La Frano, Johannes Fahrmann, Dmitry Grapov, Jose A Viscarra, John W Newman, Oliver Fiehn, Daniel E Crocker, Fabian V Filipp, Rudy M Ortiz

Open access · greenAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Exogenous GLP-1 stimulates TCA cycle and suppresses gluconeogenesis and ketogenesis in late-fasted northern elephant seals pups.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Keedrian I OlmsteadSystems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California, Merced.
Michael R La FranoNIH West Coast Metabolomics Center, University of California, Davis.
Johannes FahrmannNIH West Coast Metabolomics Center, University of California, Davis.
Dmitry GrapovNIH West Coast Metabolomics Center, University of California, Davis.
Jose A ViscarraMolecular Cell Biology, School of Natural Sciences, University of California, Merced, USA.
John W NewmanNIH West Coast Metabolomics Center, University of California, Davis.
Oliver FiehnNIH West Coast Metabolomics Center, University of California, Davis.
Daniel E CrockerBiology, Sonoma State University, Rohnert Park, USA.
Fabian V FilippSystems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California, Merced.
Rudy M OrtizMolecular Cell Biology, School of Natural Sciences, University of California, Merced, USA.
University of California, Merced · USAgricultural Research Service · USKing Abdulaziz University · SASonoma State University · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Davis · US

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Tumor pyruvate kinase as key regulator of cancer metabolismR00CA154887 · NCI · UNIVERSITY OF CALIFORNIA, MERCED · PI FILIPP, FABIAN VOLKER · 2012 to 2014
$725k
Independent Scientist Development Award in Oxidative Stress and ApneaK02HL103787 · NHLBI · UNIVERSITY OF CALIFORNIA, MERCED · PI ORTIZ, RUDY M · 2010 to 2013
$415k
Tumor pyruvate kinase as key regulator of cancer metabolismK99CA154887 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FILIPP, FABIAN VOLKER · 2011 to 2012
$177k
NCI NIH HHS K99 CA154887NCI NIH HHS R00 CA154887NHLBI NIH HHS K02 HL103787NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

introductionProlonged fasting in northern elephant seals (NES) is characterized by a reliance on lipid metabolism, conservation of protein, and reduced plasma insulin. During early fasting, glucose infusion previously reduced plasma free fatty acids (FFA); however, during late-fasting, it induced an atypical elevation in FFA despite comparable increases in insulin during both periods suggestive of a dynamic shift in tissue responsiveness to glucose-stimulated insulin secretion.

objectiveTo better assess the contribution of insulin to this fasting-associated shift in substrate metabolism.

methodsWe compared the responses of plasma metabolites (amino acids (AA), FFA, endocannabinoids (EC), and primary carbon metabolites (PCM)) to an insulin infusion (65 mU/kg) in early- and late-fasted NES pups (n = 5/group). Plasma samples were collected prior to infusion (T0) and at 10, 30, 60, and 120 min post-infusion, and underwent untargeted and targeted metabolomics analyses utilizing a variety of GC-MS and LC-MS technologies.

resultsIn early fasting, the majority (72%) of metabolite trajectories return to baseline levels within 2 h, but not in late fasting indicative of an increase in tissue sensitivity to insulin. In late-fasting, increases in FFA and ketone pools, coupled with decreases in AA and PCM, indicate a shift toward lipolysis, beta-oxidation, ketone metabolism, and decreased protein catabolism. Conversely, insulin increased PCM AUC in late fasting suggesting that gluconeogenic pathways are activated. Insulin also decreased FFA AUC between early and late fasting suggesting that insulin suppresses triglyceride hydrolysis.

conclusionNaturally adapted tolerance to prolonged fasting in these mammals is likely accomplished by suppressing insulin levels and activity, providing novel insight on the evolution of insulin during a condition of temporary, reversible insulin resistance.

Indexed as

EndocannabinoidsFatty acidsLipidomicsMetabolomicsSubstrate metabolism

Identifiers

PMID28757815
PMCPMC5526460
OpenAlexW2599175437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.